{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:11:51Z","timestamp":1757621511986,"version":"3.44.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-05041-8","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T06:44:52Z","timestamp":1754289892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The elevated levels of soluble growth stimulation expressed gene 2 are associated with coronary atherosclerotic plaque destabilization in unstable angina patients: a case control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Ning","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuewen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"25","key":"5041_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J AM COLL CARDIOL. 2020;76(25):2982\u20133021.","journal-title":"J AM COLL CARDIOL"},{"issue":"5","key":"5041_CR2","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","volume":"20","author":"R Virmani","year":"2000","unstructured":"Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscl Throm Vas. 2000;20(5):1262\u201375.","journal-title":"ARTERIOSCL THROM VAS"},{"issue":"2","key":"5041_CR3","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.4244\/EIJ-D-21-00089","volume":"17","author":"ZA Ali","year":"2021","unstructured":"Ali ZA, Karimi GK, Mintz GS, Maehara A, Shlofmitz RA, Mattesini A. Intracoronary optical coherence tomography: state of the Art and future directions. Eurointervention. 2021;17(2):e105\u201323.","journal-title":"EUROINTERVENTION"},{"issue":"5","key":"5041_CR4","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"GS Mintz","year":"2001","unstructured":"Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, et al. American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol. 2001;37(5):1478\u201392.","journal-title":"J AM COLL CARDIOL"},{"issue":"12","key":"5041_CR5","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jacc.2011.09.079","volume":"59","author":"GJ Tearney","year":"2012","unstructured":"Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, et al. Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the international working group for intravascular optical coherence tomography standardization and validation. J Am Coll Cardiol. 2012;59(12):1058\u201372.","journal-title":"J AM COLL CARDIOL"},{"issue":"5","key":"5041_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23(5):479\u201390.","journal-title":"Immunity"},{"issue":"7 Suppl","key":"5041_CR7","doi-asserted-by":"publisher","first-page":"B3","DOI":"10.1016\/j.amjcard.2015.01.034","volume":"115","author":"DA Pascual-Figal","year":"2015","unstructured":"Pascual-Figal DA, Januzzi JL. The biology of ST2: the international ST2 consensus panel. Am J Cardiol. 2015;115(7 Suppl):B3\u20137.","journal-title":"AM J CARDIOL"},{"issue":"4","key":"5041_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jchf.2016.09.010","volume":"5","author":"A Aimo","year":"2017","unstructured":"Aimo A, Vergaro G, Passino C, Ripoli A, Ky B, Miller WL, et al. Prognostic value of soluble suppression of Tumorigenicity-2 in chronic heart failure: A Meta-Analysis. JAcc-Heart Fail. 2017;5(4):280\u20136.","journal-title":"JACC-HEART FAIL"},{"issue":"9","key":"5041_CR9","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.amjmed.2017.02.034","volume":"130","author":"WS Jenkins","year":"2017","unstructured":"Jenkins WS, Roger VL, Jaffe AS, Weston SA, AbouEzzeddine OF, Jiang R, et al. Prognostic value of soluble ST2 after myocardial infarction: A community perspective. Am J Med. 2017;130(9):1112\u20139.","journal-title":"AM J MED"},{"issue":"2","key":"5041_CR10","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.4049\/jimmunol.1000520","volume":"185","author":"JE McLaren","year":"2010","unstructured":"McLaren JE, Michael DR, Salter RC, Ashlin TG, Calder CJ, Miller AM, et al. IL-33 reduces macrophage foam cell formation. J Immunol. 2010;185(2):1222\u20139.","journal-title":"J IMMUNOL"},{"issue":"6","key":"5041_CR11","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI30634","volume":"117","author":"S Sanada","year":"2007","unstructured":"Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest. 2007;117(6):1538\u201349.","journal-title":"J CLIN INVEST"},{"issue":"6","key":"5041_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCHEARTFAILURE.109.873240","volume":"2","author":"K Seki","year":"2009","unstructured":"Seki K, Sanada S, Kudinova AY, Steinhauser ML, Handa V, Gannon J, et al. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circ-Heart Fail. 2009;2(6):684\u201391.","journal-title":"CIRC-HEART FAIL"},{"issue":"2","key":"5041_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.20071868","volume":"205","author":"AM Miller","year":"2008","unstructured":"Miller AM, Xu D, Asquith DL, Denby L, Li Y, Sattar N, et al. IL-33 reduces the development of atherosclerosis. J Exp Med. 2008;205(2):339\u201346.","journal-title":"J EXP MED"},{"issue":"7","key":"5041_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/MCA.0000000000000851","volume":"31","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Fan Z, Liu H, Ma J, Zhang M. Correlation of plasma soluble suppression of tumorigenicity-2 level with the severity and stability of coronary atherosclerosis. Coron Artery Dis. 2020;31(7):628\u201335.","journal-title":"Coron ARTERY DIS"},{"issue":"14","key":"5041_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","volume":"42","author":"JP Collet","year":"2021","unstructured":"Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289\u2013367.","journal-title":"EUR HEART J"},{"key":"5041_CR16","doi-asserted-by":"crossref","unstructured":"Medina-Leyte DJ, Zepeda-Garcia O, Dominguez-Perez M, Gonzalez-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci 2021, 22(8).","DOI":"10.3390\/ijms22083850"},{"issue":"5","key":"5041_CR17","doi-asserted-by":"publisher","first-page":"e156315","DOI":"10.1371\/journal.pone.0156315","volume":"11","author":"A Marzullo","year":"2016","unstructured":"Marzullo A, Ambrosi F, Inchingolo M, Manca F, Devito F, Angiletta D, et al. ST2L transmembrane receptor expression: an immunochemical study on endarterectomy samples. PLoS One. 2016;11(5):e156315.","journal-title":"PLoS ONE"},{"issue":"10","key":"5041_CR18","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/emmm.201201374","volume":"4","author":"L Cardilo-Reis","year":"2012","unstructured":"Cardilo-Reis L, Gruber S, Schreier SM, Drechsler M, Papac-Milicevic N, Weber C, et al. Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype. Embo Mol Med. 2012;4(10):1072\u201386.","journal-title":"EMBO MOL MED"},{"issue":"1","key":"5041_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","volume":"7","author":"P Kong","year":"2022","unstructured":"Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Tar. 2022;7(1):131.","journal-title":"SIGNAL TRANSDUCT TAR"},{"key":"5041_CR20","doi-asserted-by":"crossref","unstructured":"Rangarajan S, Orujyan D, Rangchaikul P, Radwan MM. Critical Role of Inflammation and Specialized Pro-Resolving Mediators in the Pathogenesis of Atherosclerosis. Biomedicines 2022, 10(11).","DOI":"10.3390\/biomedicines10112829"},{"issue":"36","key":"5041_CR21","doi-asserted-by":"publisher","first-page":"26369","DOI":"10.1074\/jbc.M704916200","volume":"282","author":"H Hayakawa","year":"2007","unstructured":"Hayakawa H, Hayakawa M, Kume A, Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem. 2007;282(36):26369\u201380.","journal-title":"J BIOL CHEM"},{"key":"5041_CR22","doi-asserted-by":"publisher","first-page":"924461","DOI":"10.3389\/fcvm.2022.924461","volume":"9","author":"J Zhang","year":"2022","unstructured":"Zhang J, Chen Z, Ma M, He Y. Soluble ST2 in coronary artery disease: clinical biomarkers and treatment guidance. Front Cardiovasc Med. 2022;9:924461.","journal-title":"FRONT CARDIOVASC MED"},{"issue":"12","key":"5041_CR23","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1161\/CIRCULATIONAHA.117.029870","volume":"136","author":"F Crea","year":"2017","unstructured":"Crea F, Libby P. Acute coronary syndromes: the way forward from mechanisms to precision treatment. Circulation. 2017;136(12):1155\u201366.","journal-title":"Circulation"},{"issue":"11","key":"5041_CR24","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16(11):676\u201389.","journal-title":"NAT REV IMMUNOL"},{"key":"5041_CR25","doi-asserted-by":"crossref","unstructured":"Xia S, Zhang X, Zheng S, Khanabdali R, Kalionis B, Wu J et al. An Update on Inflamm-Aging: Mechanisms, Prevention, and Treatment. J Immunol Res 2016, 2016:8426874.","DOI":"10.1155\/2016\/8426874"},{"key":"5041_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijcard.2018.05.056","volume":"267","author":"A Aimo","year":"2018","unstructured":"Aimo A, Migliorini P, Vergaro G, Franzini M, Passino C, Maisel A, et al. The IL-33\/ST2 pathway, inflammation and atherosclerosis: trigger and target? Int J Cardiol. 2018;267:188\u201392.","journal-title":"INT J CARDIOL"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05041-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05041-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:26:17Z","timestamp":1757337977000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05041-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5041"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05041-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"23 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out following the Declaration of Helsinki and approved by the Ethics Committee of the Shanxi Bethune Hospital, and all study subjects gave written informed consent (ethics approval number YXLL-2023-238).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"576"}}